Associated Papers
Methadone metabolism and cytochrome P450 polymorphisms: a systematic review and meta-analysis.
Eum S et al.
Expert Opinion on Drug Metabolism & Toxicology, 2024
Severe and prolonged cyclophosphamide-induced hepatotoxicity in a breast cancer patient carrying a CYP2B6*7 variant.
Ming Z et al.
Pharmacogenomics, 2019
Gene polymorphisms and contents of cytochrome P450s have only limited effects on metabolic activities in human liver microsomes.
Gao N et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences, 2016
Cytochrome P450 variations in different ethnic populations.
McGraw J et al.
Expert Opinion on Drug Metabolism & Toxicology, 2012
Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response.
Fonseca F et al.
Plos One, 2011
Haplotype structure and allele frequencies of CYP2B6 in Spaniards and Central Americans.
Arenaz I et al.
Fundamental & Clinical Pharmacology, 2010
Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam.
Veiga MI et al.
European Journal of Clinical Pharmacology, 2009
Efavirenz induces CYP2B6-mediated hydroxylation of bupropion in healthy subjects.
Robertson SM et al.
Journal of Acquired Immune Deficiency Syndromes (1999), 2008
Do single nucleotide polymorphisms in xenobiotic metabolizing genes determine breast cancer susceptibility and treatment outcomes?
Singh V et al.
Cancer Investigation, 2008
Overview of the pharmacogenetics of HIV therapy.
Rodríguez-Nóvoa S et al.
The Pharmacogenomics Journal, 0
Select a paper to view details